Cardiac magnetic resonance assessment of mechanical dyssynchrony

Current Opinion in Cardiology

Volumn 23, Issue 5, 2008, Pages 440-446

  Helm, Robert H ^a   Lardo, Albert C ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cardiac dyssynchrony; Cardiac resynchronization therapy; Heart failure; Magnetic resonance imaging; Tagged MRI

Indexed keywords

CARDIAC RESYNCHRONIZATION THERAPY; CONTRAST ENHANCEMENT; ECHOCARDIOGRAPHY; HEART DISEASE; HUMAN; MECHANICAL DYSSYNCHRONY; NUCLEAR MAGNETIC RESONANCE; OUTCOME ASSESSMENT; PATIENT SELECTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RELIABILITY; REVIEW; ECHOGRAPHY; HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART PACING; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PROGNOSIS;

CARDIAC PACING, ARTIFICIAL; HEART FAILURE; HUMANS; MAGNETIC RESONANCE IMAGING; PROGNOSIS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 58149182158     PISSN: 02684705     EISSN: None     Source Type: Journal    
DOI: 10.1097/HCO.0b013e32830b3865     Document Type: Review

References (47)

1. Kass DA. Ventricular resynchronization: pathophysiology and identification of responders. Rev Cardiovasc Med 2003; 4 (Suppl 2):S3-S13.
2. Bleeker GB, Schalij MJ, Molhoek SG, et al. Relationship between QRS duration and left ventricular dyssynchrony in patients with end-stage heart failure. J Cardiovasc Electrophysiol 2004; 15:544-549.
3. Fauchier L, Marie O, Casset-Senon D, et al. Interventricular and intraventri-cular dyssynchrony in idiopathic dilated cardiomyopathy. A prognostic study with fourier phase analysis of radionuclide angioscintigraphy. J Am Coll Cardiol 2002; 40:2022-2030.
4. Pitzalis MV, Iacoviello M, Romito R, et al. Cardiac resynchronization therapy tailored by echocardiographic evaluation of ventricular asynchrony. J Am Coll Cardiol 2002; 40:1615-1622.
5. Reuter S, Garrigue S, Barold SS, et al. Comparison of characteristics in responders versus nonresponders with biventricular pacing for drug-resistant congestive heart failure. Am J Cardiol 2002; 89:346-350.
6. Leclercq C, Faris O, Tunin R, et al. Systolic improvement and mechanical resynchronization does not require electrical synchrony in the dilated failing heart with left bundle-branch block. Circulation 2002; 106:1760-1763.
7. Oguz E, Dagdeviren B, Bilsel T, et al. Echocardiographic prediction of long-term response to biventricular pacemaker in severe heart failure. Eur J Heart Fail 2002; 4:83-90.
8. Sogaard P, Egeblad H, Kim WY, et al. Tissue Doppler imaging predicts improved systolic performance and reversed left ventricular remodeling during long-term cardiac resynchronization therapy. J Am Coll Cardiol 2002; 40:723-730.
9. Breithardt OA, Stellbrink C, Kramer AP, et al. Echocardiographic quantification of left ventricular asynchrony predicts an acute hemodynamic benefit of cardiac resynchronization therapy. J Am Coll Cardiol 2002; 40:536-545.
10. Chung ES, Leon AR, Tavazzi L, et al. Results of the Predictors of Response to CRT (PROSPECT) trial. Circulation 2008; 117:2608-2616.
11. Gorcsan J III, Abraham T, Agler DA, et al. Echocardiography for cardiac resynchronization therapy: recommendations for performance and reporting -a report from the American Society of Echocardiography Dyssynchrony Writing Group endorsed by the Heart Rhythm Society. J Am Soc Echocar-diogr 2008; 21:191-213.
12. Zerhouni EA, Parish DM, Rogers WJ, et al. Human heart: tagging with MR imaging - a method for noninvasive assessment of myocardial motion. Radiology 1988; 169:59-63.
13. Axel L, Dougherty L MR imaging of motion with spatial modulation of magnetization. Radiology 1989; 171:841-845.
14. O'Dell WG, Moore CC, Hunter WC, et al. Three-dimensional myocardial deformations: calculation with displacement field fitting to tagged MR images. Radiology 1995; 195:829-835.
15. Osman NF, McVeigh ER, Prince JL. Imaging heart motion using harmonic phase MRI. IEEE Trans Med Imaging 2000; 19:186-202.
16. Pan L, Stuber M, Kraitchman DL, et al. Real-time imaging of regional myocardial function using fast-SENC. Magn Reson Med 2006; 55:386-395.
17. Korosoglou G, Youssef AA, Bilchick KC, et al. Real-time fast strain-encoded magnetic resonance imaging to evaluate regional myocardial function at 3.0 Tesla: Comparison to conventional tagging. J Magn Reson Imaging 2008; 27:1012-1018.
18. Delfino JG, Johnson KR, Eisner RL, et al. Three-directional myocardial phase-contrast tissue velocity MR imaging with navigator-echo gating: in vivo and in vitro study. Radiology 2008; 246:917-925.
19. Aletras AH, Ding S, Balaban RS, Wen H. DENSE: displacement encoding with stimulated echoes in cardiac functional MRI. J Magn Reson 1999; 137:247-252.
20. Gilson WD, Yang Z, French BA, Epstein FH. Measurement of myocardial mechanics in mice before and after infarction using multislice displacement-encoded MRI with 3D motion encoding. Am J Physiol Heart Circ Physiol 2005; 288:H1491 -H1497.
21. Epstein FH. MRI of left ventricular function. J Nucl Cardiol 2007; 14:729-744.
22. Helm RH, Leclercq C, Faris OP, et al. Cardiac dyssynchrony analysis using circumferential versus longitudinal strain: implications for assessing cardiac resynchronization. Circulation 2005; 111:2760-2767.
23. Waldman LK, Covell JW. Effects of ventricular pacing on finite deformation in canine left ventricles. Am J Physiol 1987; 252:H1023-H1030.
24. Waldman LK, Fung YC, Covell JW. Transmural myocardial deformation in the canine left ventricle. Normal in vivo three-dimensional finite strains. Circ Res 1985; 57:152-163.
25. Zwanenburg JJ, Gotte MJ, Kuijer JP, et al. Timing of cardiac contraction in humans mapped by high-temporal-resolution MRI tagging: early onset and late peak of shortening in lateral wall. Am J Physiol Heart Circ Physiol 2004; 286:H1872-H1880.
26. Zwanenburg JJ, Gotte MJ, Marcus JT, et al. Propagation of onset and peak time of myocardial shortening in time of myocardial shortening in ischemic versus nonischemic cardiomyopathy: assessment by magnetic resonance imaging myocardial tagging. J Am Coll Cardiol 2005; 46:2215-2222.
27. Nelson GS, Berger RD, Fetics BJ, et al. Left ventricular or biventricular pacing improves cardiac function at diminished energy cost in patients with dilated cardiomyopathy and left bundle-branch block. Circulation 2000; 102:3053-3059.
28. Helm RH, Byrne M, Helm PA, et al. Three-dimensional mapping of optimal left ventricular pacing site for cardiac resynchronization. Circulation 2007; 115:953-961.
29. Bilchick KC, Dimaano V, Wu KC, et al. Magnetic resonance imaging analysis of dyssynchrony and myocardial scar predicts function class improvement following cardiac resynchronization therapy. JACC Imaging 2008 (in press).
30. Butter C, Auricchio A, Stellbrink C, et al. Effect of resynchronization therapy stimulation site on the systolic function of heart failure patients. Circulation 2001; 104:3026-3029.
31. Chiribiri A, Kelle S, Gotze S, et al. Visualization of the cardiac venous system using cardiac magnetic resonance. Am J Cardiol 2008; 101:407-412.
32. Kim RJ, Wu E, Rafael A, et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 2000; 343:1445-1453.
33. Bleeker GB, Kaandorp TA, Lamb HJ, et al. Effect of posterolateral scar tissue on clinical and echocardiographic improvement after cardiac resynchronization therapy. Circulation 2006; 113:969-976.
34. Chalil S, Foley PW, Muyhaldeen SA, et al. Late gadolinium enhancement-cardiovascular magnetic resonance as a predictor of response to cardiac resynchronization therapy in patients with ischaemic cardiomyopathy. Europace 2007; 9:1031-1037.
35. White JA, Yee R, Yuan X, et al. Delayed enhancement magnetic resonance imaging predicts response to cardiac resynchronization therapy in patients with intraventricular dyssynchrony. J Am Coll Cardiol 2006; 48:1953-1960.
36. Fiek M, Remp T, Reithmann C, Steinbeck G. Complete loss of ICD program-mability after magnetic resonance imaging. Pacing Clin Electrophysiol 2004; 27:1002-1004.
37. Anfinsen OG, Berntsen RF, Aass H, et al. Implantable cardioverter defibrillator dysfunction during and after magnetic resonance imaging. Pacing Clin Electrophysiol 2002; 25:1400-1402.
38. Rozner MA, Burton AW, Kumar A. Pacemaker complication during magnetic resonance imaging. J Am Coll Cardiol 2005; 45:161 -162.
39. Irnich W, Irnich B, Bartsch C, et al. Do we need pacemakers resistant to magnetic resonance imaging? Europace 2005; 7:353-365.
40. Luechinger R, Duru F, Scheidegger MB, et al. Force and torque effects of a 1.5-Tesla MRI scanner on cardiac pacemakers and ICDs. Pacing Clin Electrophysiol 2001; 24:199-205.
41. Martin ET, Coman JA, Shellock FG, et al. Magnetic resonance imaging and cardiac pacemaker safety at 1.5-Tesla. J Am Coll Cardiol 2004; 43:1315-1324.
42. Luechinger R, Zeijlemaker VA, Pedersen EM, et al. In vivo heating of pacemaker leads during magnetic resonance imaging. Eur Heart J 2005; 26:376-383.
43. Gimbel JR, Johnson D, Levine PA, Wilkoff BL. Safe performance of magnetic resonance imaging on five patients with permanent cardiac pacemakers. Pacing Clin Electrophysiol 1996; 19:913-919.
44. Sommer T, Vahlhaus C, Lauck G, et al. MR imaging and cardiac pacemakers: in-vitro evaluation and in-vivo studies in 51 patients at 0.5 T. Radiology 2000; 215:869-879.
45. Gimbel JR, Kanal E, Schwartz KM, Wilkoff BL. Outcome of magnetic resonance imaging (MRI) in selected patients with implantable cardioverter defibrillators (ICDs). Pacing Clin Electrophysiol 2005; 28:270-273.
46. Nazarian S, Roguin A, Zviman MM, et al. Clinical utility and safety of a protocol for noncardiac and cardiac magnetic resonance imaging of patients with permanent pacemakers and implantable-cardioverter defibrillators at 1.5 tesla. Circulation 2006; 114:1277-1284.
47. Roguin A, Zviman MM, Meininger GR, et al. Modern pacemaker and implantable cardioverter/defibrillator systems can be magnetic resonance imaging safe: in vitro and in vivo assessment of safety and function at 1.5 T. Circulation 2004; 110:475-482.